Pharvaris (PHVS) Other Operating Expenses (2021 - 2025)

Pharvaris' (PHVS) quarterly Other Operating Expenses came in at -$0.0 in Q3 2025, up 100.0% on a QoQ basis from -$67.0 million in Q2 2025.

Pharvaris (PHVS) Other Operating Expenses (2021 - 2025) Analysis & Trends

Pharvaris (PHVS) has 5 years of Other Operating Expenses data on file, last reported at -$0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Pharvaris 2.29 Bn 1.92 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Jun 30, 2025 -67.03 Mn
Jun 30, 2024 -49.68 Mn
Mar 31, 2024 0.00
Jun 30, 2023 -31.98 Mn
Sep 30, 2022 0.00
Jun 30, 2022 -29.28 Mn
Mar 31, 2022 0.00
Sep 30, 2021 0.00